Compensatory hepatitis B cirrhosis
Showing 1 - 25 of >10,000
Cirrhosis Due to Hepatitis B Trial in Wuhan (UC-MSCs, Saline solution)
Recruiting
- Cirrhosis Due to Hepatitis B
- UC-MSCs
- Saline solution
-
Wuhan, Hubei, ChinaRenmin Hospital of Wuhan University
Aug 18, 2022
Decompensated Liver Cirrhosis Trial (Human Umbilical Cord Mesenchymal Stem Cells)
Not yet recruiting
- Decompensated Liver Cirrhosis
- Human Umbilical Cord Mesenchymal Stem Cells
- (no location specified)
Jul 13, 2023
Liver Cirrhosis, Liver Trial (Sequential Adult Left Lateral Liver Transplantation)
Not yet recruiting
- Liver Cirrhosis
- Liver
- Sequential Adult Left Lateral Liver Transplantation
- (no location specified)
Nov 22, 2023
Prevention of HCC Using Mobile Phone Applications
Not yet recruiting
- Liver Cirrhosis
- Hepatitis B
- Use of mobile health application
- +3 more
- (no location specified)
Oct 25, 2021
Hepatitis B Trial in Changsha (Peripheral iv)
Recruiting
- Hepatitis B
- Peripheral iv
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Jul 20, 2022
Hepatitis B, Portal Hypertension Trial (Atorvastatin 10mg, Placebo)
Not yet recruiting
- Hepatitis B
- Portal Hypertension
- Atorvastatin 10mg
- Placebo
- (no location specified)
Jul 29, 2022
Hepatitis B, Cirrhosis, Liver, Chronic Liver Disease Trial in Baltimore (Heplisav-B Injectable Product, 2-dose regimen,
Recruiting
- Hepatitis B
- +2 more
- Heplisav-B Injectable Product, 2-dose regimen
- Heplisav-B Injectable Product, 3-dose regimen
-
Baltimore, MarylandMercy Medical Center
Aug 24, 2022
Liver Cirrhoses Trial in Jakarta (Allogeneic Umbilical Cord Mesenchymal Stem Cell)
Recruiting
- Liver Cirrhoses
- Allogeneic Umbilical Cord Mesenchymal Stem Cell
-
Jakarta, DKI Jakarta, IndonesiaCipto Mangunkusumo hospital
Jun 12, 2022
Chronic Hepatitis b, NAFLD, Cirrhosis Trial in Hong Kong (Empagliflozin 10 MG, Placebo pills)
Recruiting
- Chronic Hepatitis b
- +5 more
- Empagliflozin 10 MG
- Placebo pills
-
Hong Kong, Hong Kong, China, Hong KongThe University of Hong Kong/Queen Mary Hospital
May 31, 2022
Hepatic Fibrosis on Hepatic Steatosis Using Ultrasound
Not yet recruiting
- Hepatic Steatosis
- +2 more
-
Seoul, Korea, Republic ofAsan Medical Center
May 21, 2023
Liver Fibrosis Trial in Beijing, Shanghai (Hydronidone capsules, The capsules)
Not yet recruiting
- Liver Fibrosis
- Hydronidone capsules
- The placebo capsules
-
Beijing, Beijing, China
- +1 more
Jun 16, 2023
Chronic Hepatitis B:Multicenter Retrospective Cohort Study
Recruiting
- Hepatitis B, Chronic
-
Amsterdam, Netherlands
- +2 more
Jan 23, 2023
Chronic Hepatitis B Virus Infection in Zambia
Active, not recruiting
- HBV
- +5 more
- Standard of care
-
Lusaka, ZambiaTropical Gastroenterology and Nutrition Group
Jun 1, 2022
Significant Liver Fibrosis in Chronic Hepatitis B Virus
Completed
- Liver Fibrosis
- (no location specified)
Sep 27, 2022
Predict Liver Fibrosis in Chronic Hepatitis B Infection
Not yet recruiting
- Fibrosis, Liver
- Liver Fibroscan
-
Assiut, EgyptAssiutU
Oct 2, 2022
Liver Cirrhosis Network Cohort Study
Recruiting
- Cirrhosis
- +10 more
-
La Jolla, California
- +13 more
Feb 21, 2023
Significant Liver Fibrosis and Inflammation in Chronic HBV
Not yet recruiting
- Chronic Hepatitis b
- (no location specified)
Aug 7, 2022
Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis Trial in United States (GALAD, Liver Ultrasound with or without AFP)
Not yet recruiting
- Carcinoma, Hepatocellular
- +3 more
- GALAD
- Liver Ultrasound with or without AFP
-
Los Angeles, California
- +9 more
Oct 18, 2023
Liver Cirrhosis Trial in Haikou (UC-MSC infusion)
Recruiting
- Liver Cirrhosis
- UC-MSC infusion
-
Haikou, ChinaHaikou People's Hospital
Oct 31, 2021
Chronic Hepatitis b, Liver Fibrosis Trial in Konya (Serum regucalcin level)
Completed
- Chronic Hepatitis b
- Liver Fibrosis
- Serum regucalcin level
-
Konya, TurkeyKonya Training and Research Hospital
Jun 23, 2022
Viral Hepatitis B, Viral Hepatitis D, Cirrhosis, Liver Trial in Worldwide (REP 2139-Mg, Tenofovir Disoproxil Fumarate, Pegylated
Available
- Viral Hepatitis B
- +6 more
- REP 2139-Mg
- +2 more
-
Vienna, Austria
- +12 more
Feb 1, 2023
Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)
Not yet recruiting
- Hepatitis C
- Cirrhosis
- Sofosbuvir/Velpatasvir + Ribavirin
- Sofosbuvir/Velpatasvir/Voxilaprevir
- (no location specified)
Jul 20, 2022
Population in Improving Eearly Diagnosis Efficancy in Chinese
Recruiting
- Carcinoma, Hepatocellular
- +4 more
- Liver cancer surveillance every 3 months
- +2 more
-
Shanghai, Shanghai, ChinaDepartment of Infectious Diseases , Ruijin Hospital, Shanghai Ji
May 13, 2023